Unraveling the complex story of immune responses to AAV vectors trial after trial.
about
Soluble interleukin 23 receptor gene therapy with adeno-associated vectors for the treatment of multiple sclerosis.Emerging Issues in AAV-Mediated In Vivo Gene Therapy.RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect.Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular DystrophyAdeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer
P2860
Unraveling the complex story of immune responses to AAV vectors trial after trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Unraveling the complex story of immune responses to AAV vectors trial after trial.
@en
type
label
Unraveling the complex story of immune responses to AAV vectors trial after trial.
@en
prefLabel
Unraveling the complex story of immune responses to AAV vectors trial after trial.
@en
P2093
P2860
P356
P1433
P1476
Unraveling the complex story of immune responses to AAV vectors trial after trial.
@en
P2093
Céline Vandamme
Federico Mingozzi
Oumeya Adjali
P2860
P304
P356
10.1089/HUM.2017.150
P577
2017-08-23T00:00:00Z
2017-11-01T00:00:00Z